Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma

Bidong Fu; Minqin Zhou; Gelin Song; Hong Zeng; Yiyang Gong; Yike Jiang; Yun Ke; Da Huang; Hong Peng; Qing Li

doi:doi:10.18632/aging.204645

← Back

Research Paper Volume 15, Issue 7 pp 2734—2771

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma

Figure 9. Functional enrichment study of TSEN54 co-expressed genes. (A) Go annotations and (B) KEGG pathways with a notable enrichment of the TSEN54 co-expression genes in HCC by LinkedOmics. (C–H) Analysis of the respective pathways enriched in high and low expression of TSEN54 and its co-expressed genes according to GSEA.